Product NewsNew Application Note Demonstrates Wyatt Technology’s MALS Instruments Characterize Novel Malaria Vaccine Candidates
Product NewsPrestigious Academic Medical Center Licenses LabVantage’s Sapphire™ for its Research & Clinical Laboratory Operations
Product NewsClinPhone Presents its Complete Range of Clinical Trial Software and Services at DIA Europe 2007
Product NewsArgenta Discovery Announces the Initiation of a Phase 1 Clinical Trial with ADC4022 – A Potential New Therapy for Chronic Obstructive Pulmonary Disease (COPD) and Severe Asthma.
Product NewsTopoTarget’s new antidote for accidental tissue exposure during chemotherapy, Savene™, becomes 'gold standard'
Product NewsBionas and PRIMACYT to cooperate on cell-based assay for prediction of hepatotoxic effects of drugs and chemicals
Product NewsACE Biosciences and US Naval Medical research Center Collaborate to Progress World’s First Campylobacter Vaccine for Travellers’ Diarrhoea Through Phase II Trials
Product NewsACE BioSciences’ Lead Product, The World’s First Commercial Vaccine For Travellers’ Diarrhoea Caused By Campylobacter, Enters Clinical Trials On Schedule
Product NewsAvastin and Xeloda meet primary endpoints in large Phase III first line metastatic colorectal cancer study
Product NewsAvastin et Xeloda remplissent les critères d'évaluation primaires d'une vaste étude de phase III sur le traitement de première ligne du cancer colo-rectal métastatique
Product NewsBioAlliance Pharma announces preliminary results of its Doxorubicin Transdrug® Phase I/II clinical trial for primary liver cancer
Product NewsBioAlliance Pharma annonce les résultats préliminaires de l’essai clinique de Phase I/II de doxorubicine Transdrug® pour le traitement du cancer primitif du foie
Product NewsUS Phase III study of Avastin in advanced pancreatic cancer does not meet primary endpoint
Product NewsReprise prochaine du recrutement dans l'étude internationale de phase III AVANT sur le traitement adjuvant postopératoire du cancer du côlon
Product NewsOxford Biomedica reports new encouraging phase II results with TroVax® and progress in the development plan
Product NewsTopoTarget and CuraGen Initiate NCI-sponsored Phase II Clinical Trial of PXD101 for Acute Myelogenous Leukemia
